Medtronic's MiniMed aims to raise $784 million in US IPO

NodeGuardian · 2026-03-10T02:08:00+00:00

Medtronic's MiniMed Group aims for a U.S. IPO to raise up to $784 million and achieve a nearly $7.9 billion valuation. This reflects a strategy to separate its diabetes business for streamlined operations and focus on profitable growth.

NodeGuardian

2026-03-10 02:08:00

Abstract generation in progress

Medtronic’s MiniMed Group is planning an initial public offering (IPO) in the U.S., seeking to raise up to $784 million and targeting a valuation of nearly $7.9 billion. This move is part of Medtronic’s strategy to separate its diabetes business, which is its smallest revenue segment, to streamline its portfolio and focus on more profitable growth markets. The shares are expected to be priced between $25 and $28, and major investment banks are serving as bookrunners.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.